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Background: Cardiogenic shock (CS) requiring mechanical circulatory support (MCS) is associated with high mortality. With improving technology, 
the outcomes of these patients are changing. We report our experience with MCS for CS. 
Methods: This is a retrospective review of adult patients who required MCS (veno-arterial extracorporeal membrane oxygenation; ECMO and 
ventricular assist device; VAD) due to CS, excluding postcardiotomy shock and graft dysfunction. ECMO was generally used for emergency or for 
unknown neurological status.
Results: From Jan/07 to Aug/11, 75 patients required MCS for CS (age 53 ± 14 yrs, 61% male). 41 patients (55%) were supported by VAD and 34 by ECMO 
(45%). The etiology of CS included acute myocardial infarction in 47%, acute decompensation of heart failure (ADHF) in 29%, and others. 60% were supported 
by IABP and 24% were undergoing CPR at the time of MCS insertion. Median length of support was 11 days (IQR, 5 - 23 days). 40 patients (53%) were 
successfully supported; 18 transitioned to a long-term VAD, 7 received a heart transplant, and 14 had myocardial recovery. 47% survived to discharge. Causes 
of death included multisystem organ failure (17) and no return of neurologic status (9). Complications included re-operation for bleeding (21%) and stroke 
(15%). Multivariable analysis showed CPR to be an independent risk factor for in-hospital mortality (OR 4.8, p = .028, Table).
Conclusions: Outcomes of CS with MCS are satisfactory. Ongoing CPR was predictive of in-hospital mortality. 
Univariable Analysis Multivariable Analysis
Variable Odds Ratio 95% CI p Odds Ratio 95% CI p 
Demographics
Age > 65 1.938 0.975 - 1.041 0.318
Male 0.417 0.147 - 1.187 0.101
HTN 0.689 0.277 - 1.713 0.423
Diabetes 0.808 0.316 - 2.063 0.655
CAD 0.829 0.333 - 2.065 0.687
COPD 0.561 0.088 - 3.570 0.541
Etiology of Acute Heart Failure
AMI 0.561 0.224 - 1.406 0.218
ADHF 0.826 0.306 - 2.239 0.709
Patient Status
Ongoing CPR 6.400 1.667 - 24.58 0.007 4.819 1.190 - 19.52 0.028
Prior CRRT 4.857 0.539 - 43.76 0.159
IABP 0.313 0.118 - 0.834 0.020 0.460 0.160 - 1.316 0.148
Baseline Laboratory Values
Lactate 1.047 0.710 - 1.543 0.818
pH 1.809 0.244 - 13.39 0.562
Creatinine 0.844 0.490 - 1.452 0.540
BUN 0.990 0.965 - 1.014 0.414
Albumin 0.588 0.297 - 1.165 0.128
Total Bilirubin 1.121 0.913 - 1.376 0.275
AST 1.000 0.999 - 1.001 0.300
ALT 1.001 0.999 - 1.002 0.386
Hematocrit 0.969 0.908 - 1.035 0.347
Platelets 0.997 0.992 - 1.002 0.346
WBC 1.003 0.927 - 1.085 0.940
Baseline Hemodynamics
MAP 0.991 0.938 - 1.047 0.743
CVP 1.006 0.914 - 1.108 0.899
